Via a prospective framework, the researchers intended to review trials on promising therapies for metastatic hormone-sensitive prostate cancer (mHSPC), by adding prostate radiotherapy to androgen deprivation therapy (ADT) or ADT alone. One ongoing (PEACE-1) and two completed (HORRAD and STAMPEDE) eligible trials were identified. On the basis of randomization sequence generation, allocation concealment, completeness of outcome data, and selective outcome reporting, a low risk of bias was noted for both the trials. However, prostate radiotherapy could not clearly improve survival or progression-free survival in unselected men with mHSPC, a clear difference in the effect by the metastatic burden on survival, with an absolute improvement in 3-yr survival in men who had four or fewer bone metastases were observed. Hence, for men with mHSPC with a low metastatic burden prostate radiotherapy should be considered.
Prostate Radiotherapy for Metastatic ... - Advanced Prostate...
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.
![GranPaSmurf profile image](https://images.hu-production.be/avatars/38c48c4b5d706944b797023746012167_small@2x_100x100.jpg)
Written by
![GranPaSmurf profile image](https://images.hu-production.be/avatars/38c48c4b5d706944b797023746012167_small@2x_100x100.jpg)
GranPaSmurf
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
apalutamide to ADT offered patients with metastatic, castration-sensitive prostate cancer improved...
FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
en-deprivation-therapy-and-docetaxel-for-metastatic-hormone-sensitive-prostate-cancer-in-the-phase-3
Advanced Hormone Sensitive Metastatic Prostate Cancer
investigation revealed Gleason 8/9 prostate cancer and three bone metastases (spine and hip),...
ADT + Abi + Docetaxel for metastatic prostate cancer?
progression-free survival in men given the triple therapy of ADT + Abi + Docetaxel therapy on...
Hi folks, are the Metastatic Hormone Sensitive Prostate Cancer (mHSPC) patients here, which, treatments are at least ADT2, taken Docetaxel?
is typical combination for mHSPC patients.
Although, the CHAARTED trial has determined - adding...